Register for a premium account to gain access to Sterling AI.
Get StartedThings you can ask Sterling:
Third of the big three US drug distributors, also a medical products manufacturer. GLP-1 sales rose significantly across fiscal 2024 and 2025 and lifted reported revenue, but the company disclosed that they did not meaningfully contribute to segment profit.
Q2 2024-Q1 2026
Q2 2024-Q1 2026
Q2 2024-Q1 2026